Dinner dishes to bring the family together
Supper with the Wallaces
Nicorette shortage concerns many former smokers
Nicorette shortage
Senate holds hearings on spread of measles
Measles outbreak
Government to scrap warning on cholesterol in diets?
Grocery stores warn of organic milk shortage
The findings of a swab test in the NYC subway system
NYC subway swab test
Measles outbreak worsens
Measles outbreak
Are hospitals a bad place to have a heart attack?
Improving in-hospital heart-attack protocols
Super Bowl: U.S. pigs out
Super Bowl binge eating
Should the government mandate vaccinations?
Measles outbreak grows
The growing trend of ‘smart drugs’
‘Smart Drug’ supplements
Buy health insurance or pay ObamaCare penalty?
Health insurance coverage vs. Obamacare fee
Melissa Rivers sues Manhattan clinic over her mother’s death
Rivers’ malpractice suit
Avoiding the health risks from the cold and snow
Staying healthy during the winter
Study links e-cigs to formaldehyde, cancer risk
Formaldehyde in e-cigs?
Time-restricted eating for better health?
Your eating clock
Is pet insurance worth it?
The real costs of pet insurance
Does Charles Payne think he’s smarter because he stays up late?
Night owl = Genius?
Analysis: For Merck, bringing cattle feed Zilmax back won't be easy
U.S. pharmaceutical giant Merck & Co faces significant challenges bringing its controversial feed additive Zilmax back to market in the United States and Canada, even after a vote of confidence from South Korea on Thursday.
Royalty Pharma Drops Hostile Bid for Elan
Royalty Pharma's $8 billion bid for the Irish drug firm lapsed when it withdrew an appeal against a ruling by Ireland's regulator on takeover bids.
AstraZeneca to Pay Up to $1.15B for Pearl Therapeutics
The biopharmaceutical business is buying privately-held Pearl Therapeutics for up to $1.15 billion to build its portfolio of respiratory disease drugs.